< 1 minute read
Nov. 26, 2021
IM156: An Oral Protein-Complex 1 (OXPHOS) Inhibitor
IM156
oral protein-complex 1 (OXPHOS) inhibitor 200-800 mg QD, phase I, cancer/IPF from metformin J. Pharmacol. Exp. Ther. ImmunoMet Therapeutics
Loading...
oral protein-complex 1 (OXPHOS) inhibitor 200-800 mg QD, phase I, cancer/IPF from metformin J. Pharmacol. Exp. Ther. ImmunoMet Therapeutics